Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Uterine Cervical Neoplasms × Data Collection × Clear all

Status

Completed 4 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1

Interventions

Cisplatin 37 Radiotherapy 17 Brachytherapy 16 Paclitaxel 15 Carboplatin 15 Bevacizumab 6 Drug Therapy 5 toripalimab 4 camrelizumab 4 Gemcitabine 4 pembrolizumab 3 nimotuzumab 3 apatinib 3 Vaccines 3 Neoadjuvant Therapy 3 tislelizumab 2 nedaplatin 2 Topotecan 2 TP protocol 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Mindfulness 2 Mass Screening 2 Interleukin-2 2 Diathermy 2 DNA Methylation 2 Cetuximab 2 Blood Specimen Collection 2 Albumin-Bound Paclitaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06208319 2024-02-01

IACOL

Assistance Publique - Hôpitaux de Paris

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡